GlassScriptPhysician profile
Katelyn Fleischman
NPI 1578241840
$5,650.19
in general payments reported to CMS, 2019-2025
12 companies · $2,132 in 2025
The $2,132 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $553 · 2024: $2,965 · 2025: $2,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,400 · Honoraria: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,400.19 |
| Honoraria | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $1,437.64 | 2024-2025 | |
| Harrow Eye, LLC | $830.52 | 2024-2025 | Vevye |
| Bausch & Lomb Americas INC. | $764.74 | 2023-2025 | Infuse, Miebo, Xiidra |
| Tarsus Pharmaceuticals, INC. | $697.19 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $383.34 | 2023-2025 | Oxervate |
| Alcon Vision LLC | $360.44 | 2024-2025 | Precision7, Dailies Total1, Precision 1 |
| Coopervision INC. | $260.95 | 2023-2025 | Clariti Contact Lens, Misight Contact Lens, Myday Contact Lens |
| Biotissue Holdings INC. | $254.15 | 2024 | |
| Johnson & Johnson Vision Care, INC. | $251.20 | 2023-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $217.51 | 2023-2025 | Cequa |
| Oyster Point Pharma, INC. | $169.69 | 2023-2024 | Tyrvaya |
| Alimera Sciences, INC. | $22.82 | 2024 | Yutiq, Iluvien |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Fleischman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.